Related Experiment Video
Updated: Sep 18, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Left Atrial Volume Index, Left Ventricular Outflow Tract Gradient, and Incident Atrial Fibrillation in Hypertrophic
Oday Salman1,2, Arun Gajan Pradeep1,2, Sutopa Purkayastha1,3
1Northwell, New Hyde Park, New York, USA.
Background:
Atrial fibrillation (AF) is a common complication of hypertrophic cardiomyopathy (HCM). Whether left atrial volume index (LAVI) or resting left ventricular outflow tract (LVOT) gradient better identifies patients who develop AF is unresolved.
Objectives:
To compare baseline LAVI and resting LVOT gradient as predictors of incident AF in HCM.
Methods:
We retrospectively studied 777 patients with HCM identified by ICD-10 code I42.1 (obstructive hypertrophic cardiomyopathy). Patients with pre-existing AF or atrial flutter were excluded, leaving 547 patients. The primary exposure was baseline LAVI (available in 167 patients; 25 incident AF events), analyzed per 10-mL/m2 increment. Incident AF was defined as new AF, AF hospitalization, or cardioversion after the index date, and evaluated using Cox models. Secondary analyses assessed LVOT gradient, LAVI tertiles, time-varying mavacamten exposure, and competing risks.
Results:
During a median follow-up of 2.31 years, 60 patients developed incident AF. LAVI was independently associated with incident AF in the prespecified model adjusted for age, sex, and hypertension (adjusted HR per 10 mL/m2, 1.27; 95% CI, 1.03-1.57; p = 0.025). AF risk increased across LAVI tertiles (log-rank χ2 = 9.48; p = 0.0087). Resting LVOT gradient was also independently associated with incident AF after the same adjustment (HR per 10 mm Hg, 1.07; 95% CI, 1.00-1.15; p = 0.042; n = 190, 26 events). In a head-to-head model, neither association remained significant.
Conclusions:
In HCM, LAVI and resting LVOT gradient were each independently associated with incident AF, and neither remained significant when modeled together. LAVI may serve as a practical echocardiographic marker to refine AF risk assessment.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Heart Failure II: Pathophysiology
